Internal Medicine, Hematology & Oncology · San Antonio, TX
NPI
1548688641
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4383 Medical Dr
San Antonio, TX, 78229
Phone (210) 593-5700
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
83,220 services
Medicare patients, 2024
228
Average age 74
Drug cost, 2024
$1.4M
1,610 prescriptions
Company payments, 2025
$984
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Prathibha Surapaneni was code J0897 (injection, denosumab, 1 mg), 6,480 times for 21 patients. In total Prathibha Surapaneni billed 83,220 services in 116 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 6,480 | 21 | $20.40 | $132K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,404 | 20 | $0.09 | $124 |
| 80053 Clinical Chemistry | Office | 389 | 103 | $10.32 | $4,016 |
| 85025 Blood Count | Office | 365 | 103 | $7.59 | $2,770 |
| 96367 Intravenous Infusion, Hydration | Office | 272 | 27 | $21.81 | $5,931 |
| 36415 Venipuncture Blood Collection | Office | 271 | 110 | $8.65 | $2,344 |
| 99214 Office E&M - Established | Office | 269 | 166 | $92.54 | $25K |
| 96413 Chemotherapy Administration | Office | 182 | 26 | $98.45 | $18K |
| 99215 Office E&M - Established | Office | 155 | 49 | $125.42 | $19K |
| 96372 Injection Administration | Office | 152 | 32 | $10.84 | $1,647 |
| 96375 Injection Administration | Office | 119 | 16 | $11.80 | $1,404 |
| 86300 Immunoassay | Office | 89 | 27 | $20.39 | $1,815 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 83 | 12 | $0.65 | $53.57 |
| 82378 Clinical Chemistry | Office | 69 | 18 | $18.58 | $1,282 |
| 85027 Blood Count | Office | 69 | 15 | $6.34 | $437 |
By year: 2022 $1.2M for 58,176 services; 2023 $1.5M for 86,412 services; 2024 $1.7M for 83,220 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 389 | 103 | $10.32 | $4,016 |
| 85025 Blood Count | 365 | 103 | $7.59 | $2,770 |
| 36415 Venipuncture Blood Collection | 271 | 110 | $8.65 | $2,344 |
| 86300 Immunoassay | 89 | 27 | $20.39 | $1,815 |
| 82378 Clinical Chemistry | 69 | 18 | $18.58 | $1,282 |
| 85027 Blood Count | 69 | 15 | $6.34 | $437 |
| 83735 Clinical Chemistry | 38 | 27 | $6.40 | $243 |
| 83540 Clinical Chemistry | 31 | 24 | $6.34 | $197 |
| 83550 Clinical Chemistry | 30 | 23 | $8.57 | $257 |
| 82728 Clinical Chemistry | 30 | 23 | $13.36 | $401 |
Medicare prescription drug claims, 2024
In 2024, the drug Prathibha Surapaneni prescribed most often to Medicare patients was Anastrozole, with 267 prescriptions and refills. In total Prathibha Surapaneni wrote 1,610 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 267 | 708 | 79 | $5,731 |
| Tamoxifen Citrate Generic | 194 | 525 | 61 | $5,151 |
| Letrozole Generic | 100 | 213 | 27 | $2,121 |
| Potassium Chloride Generic | 76 | 78 | 36 | $338 |
| Gabapentin Generic | 71 | 97 | 16 | $778 |
| Duloxetine Hcl Generic | 52 | 67 | 13 | $604 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 40 | 40 | 12 | $1,194 |
| Eliquis Apixaban | 39 | 47 | 13 | $26K |
| Kisqali Ribociclib Succinate | 30 | 30 | Under 11 | $350K |
| Hydroxyurea Generic | 29 | 37 | Under 11 | $1,528 |
| Ondansetron Hcl Generic | 29 | 29 | 16 | $370 |
| Olanzapine Generic | 29 | 31 | 12 | $306 |
| Promethazine Hcl Generic | 26 | 26 | 16 | $389 |
| Alprazolam Generic | 25 | 27 | 11 | $97.04 |
| Sodium Chloride 0.9 % Sodium Chloride | 22 | 22 | Under 11 | $93.11 |
Brand drugs: - claims; generic drugs: 1,372 claims; opioid claims: 88.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Prathibha Surapaneni $984 ($984 in general payments such as food, travel and fees) from 15 companies. The largest payer was Daiichi Sankyo Inc. with $186.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 8 | $186 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $152 |
| Lilly USA, LLC LLY | 11 | $151 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $113 |
| Gilead Sciences, Inc. GILD | 5 | $90.61 |
| Pfizer Inc. PFE | 3 | $60.65 |
| Celgene Corporation BMY | 2 | $39.69 |
| Genentech USA, Inc. ROG.SW | 1 | $31.05 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $30.29 |
| BeOne Medicines USA, Inc. ONC | 1 | $27.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.